Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life.
    Benzinga,  Biotechnology,  Health,  Nature,  Regenerative Medicine

    Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    June 15, 2022 /

    Originally Published on Benzinga Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life. The global regenerative medicine market  is estimated to reach $6.49 billion in 2027, up 9.3% from $3.05 billion in 2019. …

    read more
    Jessica N. Abraham Comments Off on Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    You May Also Like

    Startup, Biotricity, Bioflux, Biokit, Bioheart, Samsung Watch4, Waqaas Al Siddiq

    Healthy Hearts and Healthy Wallets: Why one HealthTech Startup is a Must-Invest

    July 14, 2021
    parcelpost parcelpal Last week, ParcelPal Logistics Inc. (OTCQB: PTNYF), a US and Canadian-based organization specializing in last-mile delivery services and logistics-related solutions, announced that it would acquire another well-known and currently unnamed U.S. delivery service, citing a “letter of intent” between both parties after almost 8 months of successful, rapidly-growing co-operations at the company’s west coast facility.

    US and Canadian Delivery Service to Acquire Another U.S. Delivery Services Company, Executes New Canadian Service Agreement in the Same Week

    December 2, 2021
    Cell Transplant, Eye Transplant, Cellular Regeneration, Regeneration Therapy,

    Lineage, Pioneering a New Branch of Medicine — OpRegen Continues to Show Promising Results in Dry AMD with Geographic Atrophy

    October 21, 2021
  • Statera Pharmaceuticals treatment for Covid-19 Long-Haulers
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    October 28, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) recently announced that it has officially received Institutional Review Board (IRB) approval to conduct a Phase 1 pilot study at Loma Linda University Health to evaluate STAT-205 as a treatment in the mitigation of SARS-CoV-2 progression. STAT-205 is a breakthrough immuno-modulator designed to decrease elevated inflammatory responses that are associated with viral infections and inhibit viral replication in human lung cells. Its efficacy was successfully demonstrated during preclinical in vitro studies, where STAT-205 was able to inhibit the replication of…

    read more
    Jessica N. Abraham Comments Off on Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    You May Also Like

    Hemp-based animal bedding for small animals and farms -- pest free, pesticide free, mold-free, antibacterial, safe, edible.

    Industrial Hemp: Big Win for Pet Stores, Farmers, and Animals

    October 25, 2021
    Generation Hemp is a Pure-Play industrial hemp company that focuses on providing sustainability within the industrial hemp sector.

    Is Generation Hemp Now A Leader in Pure-Play Hemp Operations for the Industrial Sector?

    October 28, 2021
    Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life.

    Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    June 15, 2022
  • Goats, Animal Bedding, anti-pest, anti-mold, anti-bacterial, industrial hemp industry,
    Animals,  Benzinga,  Business,  Cannabis,  Farming,  Finance,  Health,  Hemp,  Industry,  Nature

    Research Shows that Animals, too, Need a Good Night’s Sleep

    September 14, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. There’s a genetic link between narcolepsy, sleeping with one eye open and the so-called “fear conditioning” of so many different animals on this planet. A lack of sleep is not only dangerous to the health of humans but it also puts the health of these animals at risk, no matter their shape, size or species. Social hierarchy, diet, brain size and body mass are contributing factors to how much sleep particular animals naturally need. Outside factors might even include their immediate environment and a…

    read more
    Jessica N. Abraham Comments Off on Research Shows that Animals, too, Need a Good Night’s Sleep

    You May Also Like

    Top Tech Startups San Fransciso

    BEST TECH STARTUPS IN SAN FRANCISCO, RANKED

    August 11, 2021
    Hemp-based animal bedding for small animals and farms -- pest free, pesticide free, mold-free, antibacterial, safe, edible.

    Industrial Hemp: Big Win for Pet Stores, Farmers, and Animals

    October 25, 2021
    Generation Hemp is a pure-play leader in the industrial hemp industry.

    Generation Hemp Reports Quarterly Financial Statements to SEC, Announces New Processing Contracts and Brand Launches

    August 21, 2021
  • Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets.  This change in name comes as a natural progression, as the company shifts gears toward placing a more strategic focus on restoring total immune health — including autoimmune and inflammatory diseases, such as fibromyalgia and multiple sclerosis, blood disorders like anemia and lupus, even cancer and various other infectious diseases.  The company began trading as CLBI, last month,…

    read more
    Jessica N. Abraham Comments Off on Statera BioPharma: The Ticker Formerly Known as CBLI

    You May Also Like

    Cadiac heart monitoring

    Biotricity Invites Physicians to Join Shared Revenue Opportunity, Provides Clinics with Remote Devices for Improved Monitoring and Diagnosis

    November 11, 2021
    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021
    Smart Buildings, HVAC, Indoor Air Quality, WiFi, Connected Devices, Internet of things, IoT,

    Delphi360™ to Officially Launch, Improve the Work Environment and Change Indoor Air Quality Forever

    September 7, 2021
  • Medtech Cardiac Monitoring Device, Wearable, Biotricity, Bioflux, Samsung, Watch4,
    Business,  Benzinga,  Finance,  Health,  IoT,  Medtech,  Technology,  Wearable Devices

    Biotricity Reports Q1 Earnings at 290% for FY2022

    September 2, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always connected, these wearable devices have been giving power back to those suffering from chronic cardiac conditions and simultaneous comorbidities — the simultaneous presence of two or more diseases or medical conditions and often relative of one another.  Through remote heart monitoring and diagnostic technologies, doctors can screen their patients from a distance, even alerted to a possible emergency if the…

    read more
    Jessica N. Abraham Comments Off on Biotricity Reports Q1 Earnings at 290% for FY2022

    You May Also Like

    Next Generation Communications, IP Transformation, Advanced Broadband Networks, Digital Lifestyles, Eco-Sustainable Telco Solutions, Dynamic Enterprise, Service Delivery Environment, Advanced Broadband Networks, End to End Transformation, Advanced Business Models, Business Transformation, Services Transformation, Service Delivery Platform, Killer Telco Environment and Managed Telco Services, Next Generation Communications, IP Transformation, Advanced Broadband Networks, Digital Lifestyles, Eco-Sustainable Telco Solutions, Dynamic Enterprise, Service Delivery Environment, Advanced Broadband Networks, End to End Transformation, Advanced Business Models, Business Transformation, Services Transformation, Service Delivery Platform, Killer Telco Environment and Managed Telco Services

    New York City Will Be America’s First Smart City

    January 11, 2016
    Network Functions Virtualization, NFZ, NFZ Zone, AWS, Cloud, Cloud Computing, Explained, Key Terms, PaaS, SaaS, Data Science, Deep Learning, Machine Learning,IaaS, Cloud Portability, Remote Access, Security, Vertical Cloud, Consumer Cloud, Server, Network, Hybrid Systems, Multi-Tenancy, Xaas, Anything-as-a-Service, DaaS, PaaS, Software-as-a-Service, Software Applications, Work Solutions, Business Solutions, Enterprise Solutions, Remote Workforce, Productivity, Workforce Optimization, Platform-as-a-Service, Infrastructure-as-a-Service,Flexibility,Private Networks, Virtual Private Networks, VPN, Virtualization,

    Telefonica and Juniper Networks Enforce Rich Content Delivery Through New Infrastructure Delivery

    February 29, 2016
    Age-Related Macular Degeneration DRY AMD, Lineage Cell Therapeutics

    Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    August 11, 2021
 Older Posts
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.